Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compatible Dose Study and Effect Observation of Remimazolam Besylate Combined With Afentanil for Awake Endotracheal Intubation

NCT06026566 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06026566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06026566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compatible Dose Study and Effect Observation of Remimazolam Besylate Combined With Afentanil for Awake Endotracheal Intubation
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
December 31, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

awake endotracheal intubation, remimazolam